These results indicate that NSLC01 selectively induces apoptosis of pancreatic cancer cells with high NRF2 activation, and the effect appears to be independent of NRF2 transcriptional activity or ROS production. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.